1. Home
  2. UBX vs SIF Comparison

UBX vs SIF Comparison

Compare UBX & SIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • SIF
  • Stock Information
  • Founded
  • UBX 2009
  • SIF 1913
  • Country
  • UBX United States
  • SIF United States
  • Employees
  • UBX N/A
  • SIF N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • SIF Office Equipment/Supplies/Services
  • Sector
  • UBX Health Care
  • SIF Industrials
  • Exchange
  • UBX Nasdaq
  • SIF Nasdaq
  • Market Cap
  • UBX 20.4M
  • SIF 17.5M
  • IPO Year
  • UBX 2018
  • SIF N/A
  • Fundamental
  • Price
  • UBX $1.06
  • SIF $2.80
  • Analyst Decision
  • UBX Strong Buy
  • SIF
  • Analyst Count
  • UBX 3
  • SIF 0
  • Target Price
  • UBX $5.33
  • SIF N/A
  • AVG Volume (30 Days)
  • UBX 227.8K
  • SIF 4.2K
  • Earning Date
  • UBX 05-13-2025
  • SIF 05-08-2025
  • Dividend Yield
  • UBX N/A
  • SIF N/A
  • EPS Growth
  • UBX N/A
  • SIF N/A
  • EPS
  • UBX N/A
  • SIF N/A
  • Revenue
  • UBX N/A
  • SIF $85,042,000.00
  • Revenue This Year
  • UBX N/A
  • SIF N/A
  • Revenue Next Year
  • UBX N/A
  • SIF N/A
  • P/E Ratio
  • UBX N/A
  • SIF N/A
  • Revenue Growth
  • UBX N/A
  • SIF 41.17
  • 52 Week Low
  • UBX $0.94
  • SIF $2.73
  • 52 Week High
  • UBX $3.10
  • SIF $5.96
  • Technical
  • Relative Strength Index (RSI)
  • UBX 31.85
  • SIF 36.51
  • Support Level
  • UBX $1.16
  • SIF $2.73
  • Resistance Level
  • UBX $1.22
  • SIF $2.91
  • Average True Range (ATR)
  • UBX 0.13
  • SIF 0.09
  • MACD
  • UBX -0.06
  • SIF 0.02
  • Stochastic Oscillator
  • UBX 12.22
  • SIF 26.92

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About SIF SIFCO Industries Inc.

SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.

Share on Social Networks: